Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lex Wunderink

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
Schizophrenia Bulletin|August 9, 2006
Predictive validity of proposed remission criteria in first-episode schizophrenic patients responding to antipsychoticsLex Wunderink, Fokko J Nienhuis, Sjoerd Sytema, et al.
The American Journal of Psychiatry|May 2, 2017
Citalopram Discontinuation More Harmful Than Gradual Dosage Reduction?Petrus J C Krijnsen, Titus W D P van Os, Lex Wunderink
JMIR Mental Health|May 30, 2018
A Smart Screening Device for Patients with Mental Health Problems in Primary Health Care: Development and Pilot StudyJan van Bebber, Rob R Meijer, Johana Tw Wigman, et al.
The Journal of Clinical Psychiatry|May 17, 2007
Guided discontinuation versus maintenance treatment in remitted first-episode psychosis: relapse rates and functional outcomeLex Wunderink, Fokko J Nienhuis, Sjoerd Sytema, et al.
Psychiatric Services (Washington, D.C.)|October 17, 2013
E-mental health self-management for psychotic disorders: state of the art and future perspectivesLian van der Krieke, Lex Wunderink, Ando C Emerencia, et al.
International Psychogeriatrics|August 17, 2021
Five-year outcome of clinical recovery and subjective well-being in older Dutch patients with schizophreniaPaul D Meesters, Sjors M M Lange, Lex Wunderink, et al.
Schizophrenia Research|October 3, 2012
Duration of untreated psychosis and negative symptoms--a systematic review and meta-analysis of individual patient dataNynke Boonstra, Rianne Klaassen, Sjoerd Sytema, et al.
Schizophrenia Research|December 6, 2020
Reprint of: Negative symptoms predict high relapse rates and both predict less favorable functional outcome in first episode psychosis, independent of treatment strategyLex Wunderink, Jan van Bebber, Sjoerd Sytema, et al.
Journal of Medical Internet Research|October 9, 2013
A web-based tool to support shared decision making for people with a psychotic disorder: randomized controlled trial and process evaluationLian van der Krieke, Ando C Emerencia, Nynke Boonstra, et al.
Schizophrenia Research|December 24, 2019
Negative symptoms predict high relapse rates and both predict less favorable functional outcome in first episode psychosis, independent of treatment strategyLex Wunderink, Jan van Bebber, Sjoerd Sytema, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
Schizophrenia Bulletin|August 9, 2006
Predictive validity of proposed remission criteria in first-episode schizophrenic patients responding to antipsychoticsLex Wunderink, Fokko J Nienhuis, Sjoerd Sytema, et al.
The American Journal of Psychiatry|May 2, 2017
Citalopram Discontinuation More Harmful Than Gradual Dosage Reduction?Petrus J C Krijnsen, Titus W D P van Os, Lex Wunderink
JMIR Mental Health|May 30, 2018
A Smart Screening Device for Patients with Mental Health Problems in Primary Health Care: Development and Pilot StudyJan van Bebber, Rob R Meijer, Johana Tw Wigman, et al.
The Journal of Clinical Psychiatry|May 17, 2007
Guided discontinuation versus maintenance treatment in remitted first-episode psychosis: relapse rates and functional outcomeLex Wunderink, Fokko J Nienhuis, Sjoerd Sytema, et al.
Psychiatric Services (Washington, D.C.)|October 17, 2013
E-mental health self-management for psychotic disorders: state of the art and future perspectivesLian van der Krieke, Lex Wunderink, Ando C Emerencia, et al.
International Psychogeriatrics|August 17, 2021
Five-year outcome of clinical recovery and subjective well-being in older Dutch patients with schizophreniaPaul D Meesters, Sjors M M Lange, Lex Wunderink, et al.
Schizophrenia Research|October 3, 2012
Duration of untreated psychosis and negative symptoms--a systematic review and meta-analysis of individual patient dataNynke Boonstra, Rianne Klaassen, Sjoerd Sytema, et al.
Schizophrenia Research|December 6, 2020
Reprint of: Negative symptoms predict high relapse rates and both predict less favorable functional outcome in first episode psychosis, independent of treatment strategyLex Wunderink, Jan van Bebber, Sjoerd Sytema, et al.
Journal of Medical Internet Research|October 9, 2013
A web-based tool to support shared decision making for people with a psychotic disorder: randomized controlled trial and process evaluationLian van der Krieke, Ando C Emerencia, Nynke Boonstra, et al.
Schizophrenia Research|December 24, 2019
Negative symptoms predict high relapse rates and both predict less favorable functional outcome in first episode psychosis, independent of treatment strategyLex Wunderink, Jan van Bebber, Sjoerd Sytema, et al.
Pageof 6